Abstract
Community-acquired pneumonia (CAP) is a relatively common and potentially serious infection that affects both immunocompetent and immunosuppressive adults throughout the world. The annual incidence of CAP in the United States is approximately 4 million cases. CAP due to atypical pathogens accounts for approximately 20 to 40 percent of cases necessitating hospitalization. There are few data regards to the prevalence rates of severe CAP due to atypical pathogens necessitating admission to the intensive care unit. This review article summarizes clinical features, diagnostic criteria, differential diagnosis, and management based on guidelines of medical societies.
Keywords: Community-acquired pneumonia, atypical pathogens, legionella, mycoplasma, chlamydia, intensive care unit
Current Respiratory Medicine Reviews
Title: Severe Community-Acquired Pneumonia (CAP) due to Atypical Pathogens
Volume: 1 Issue: 3
Author(s): Argyris Michalopoulos, Michael Rizos and Matthew E. Falagas
Affiliation:
Keywords: Community-acquired pneumonia, atypical pathogens, legionella, mycoplasma, chlamydia, intensive care unit
Abstract: Community-acquired pneumonia (CAP) is a relatively common and potentially serious infection that affects both immunocompetent and immunosuppressive adults throughout the world. The annual incidence of CAP in the United States is approximately 4 million cases. CAP due to atypical pathogens accounts for approximately 20 to 40 percent of cases necessitating hospitalization. There are few data regards to the prevalence rates of severe CAP due to atypical pathogens necessitating admission to the intensive care unit. This review article summarizes clinical features, diagnostic criteria, differential diagnosis, and management based on guidelines of medical societies.
Export Options
About this article
Cite this article as:
Michalopoulos Argyris, Rizos Michael and Falagas E. Matthew, Severe Community-Acquired Pneumonia (CAP) due to Atypical Pathogens, Current Respiratory Medicine Reviews 2005; 1 (3) . https://dx.doi.org/10.2174/157339805774598009
DOI https://dx.doi.org/10.2174/157339805774598009 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bacteremic Streptococcus pneumoniae in Community-Acquired Pneumonia: An Update
Current Respiratory Medicine Reviews Emergence of Methicillin-Resistant Staphylococcus aureus (MRSA) as a Public-Health Threat and Future Directions of Antibiotic Therapy for MRSA Infections
Anti-Infective Agents Susceptibility of Periodontopathogenic and Cariogenic Bacteria to Defensins and Potential Therapeutic Use of Defensins in Oral Diseases
Current Pharmaceutical Design An Update to Enterococcal Bacteremia: Epidemiology, Resistance, and Outcome
Infectious Disorders - Drug Targets Current Indications for Infective Endocarditis Antibiotic Prophylaxis
Infectious Disorders - Drug Targets Phytochemicals as Inhibitors of Candida Biofilm
Current Pharmaceutical Design Caenorhabditis elegans: A Model for Studying Human Pathogen Biology
Recent Patents on Biotechnology Nursing Assessment, Education, and Care of Extremely Premature Neonates with Patent Ductus Arteriosus
Current Pediatric Reviews Short Term Statin Treatment Improves Survival and Differentially Regulates Macrophage-Mediated Responses to Staphylococcus aureus
Current Pharmaceutical Biotechnology Coarctation of the Aorta - The Current State of Surgical and Transcatheter Therapies
Current Cardiology Reviews Recent Advances in Treatment Approaches of Mucopolysaccharidosis VI
Current Pharmaceutical Biotechnology Pulmonary Disease in Beta-Thalassemia
Current Respiratory Medicine Reviews The Importance of Guidelines in the Development and Application of Probiotics
Current Pharmaceutical Design Prokaryotic Substrate-Binding Proteins as Targets for Antimicrobial Therapies
Current Drug Targets Rashes, Sniffles, and Stroke: A Role for Infection in Ischemic Stroke of Childhood
Infectious Disorders - Drug Targets Current Evidence on the Evaluation and Management of Fever Without a Source in Infants Aged 0-90 Days: A Review
Reviews on Recent Clinical Trials Reviewing the Cardiovascular Complications of HIV Infection After the Introduction of Highly Active Antiretroviral Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Cardiovascular Disease in Antiphospholipid Syndrome
Current Vascular Pharmacology Immunoinformatic Approach for the Identification of Potential Epitopes Against <i>Stenotrophomonas maltophilia</i>: A Global Opportunistic Pathogen
Letters in Drug Design & Discovery Human Heart Failure: A Proteomics Perspective
Current Proteomics